Top Markets
#1 Resolv wstUSR Resolv wstUSR +114.61%
#2 Luxxcoin Luxxcoin +45.15%
#3 ResearchCoin ResearchCoin +21.62%
#4 Reactive Network Reactive Network +21.45%
#5 Layer3 Layer3 +19.67%
#6 Orderly Network Orderly Network +16.55%
#7 Aria.AI Aria.AI +12.61%
#8 Bitgert Bitgert +11.76%
#9 Lisk Bridged wstETH (Lisk) Lisk Bridged wstETH (Lisk) +9.32%
#10 KAITO KAITO +9.04%
Coin of the day
Resolv wstUSR Resolv wstUSR
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
CSL Limited CSL Limited

CSL Limited

CSL
Rang in Aktien #432
CSL Limited researches, develops, manufactures, markets, and distributes... CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
Aktienkurs
$99.32
Marktkapitalisierung
$48.20B
Veränderung (1 Tag)
0.98%
Veränderung (1 Jahr)
-32.14%
Land
AU
Handel CSL Limited (CSL)

Kategorie

Healthcare
Operative Marge für CSL Limited (CSL)
Operative Marge zum April 2026 TTM: 25.72%
Laut den neuesten Finanzberichten und dem Aktienkurs von CSL Limited beträgt die aktuelle operative Marge (TTM) 25.72%. Am Ende des Jahres 2024 lag die operative Marge bei 18.82%.
Historie der operativen Marge von CSL Limited von 2000 bis 2026
Operative Marge zum Jahresende
Jahr Operative Marge ändert
2026 (TTM) 25.72% 34.10%
2025 19.18% 1.91%
2024 18.82% 17.92%
2023 15.96% -27.68%
2022 22.07% -11.97%
2021 25.07% 4.98%
2020 23.88% -17.28%
2019 28.87% 22.59%
2018 23.55% 27.09%
2017 18.53% 11.02%
2016 16.69% -35.98%
2015 26.07% 2.64%
2014 25.40% 10.82%
2013 22.92% 13.69%
2012 20.16% -7.48%
2011 21.79% -9.25%
2010 24.01% 30.70%
2009 18.37% 6.55%
2008 17.24% 0.23%
2007 17.20% 1,146.38%
2006 1.38% -84.17%
2005 8.72% 448.43%
2004 1.59% -63.95%
2003 4.41% -49.60%
2002 8.75% -193.38%
2001 -9.37% 0.00%
2000 0.00% 0.00%
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Operative Marge Differenz der operativen Marge Land
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
41.30% -98.39%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
35.45% -98.62%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
24.95% -99.03%
US
UCB SA UCB SA
UCB SA
UCB.BR
25.32% -99.02%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
25.64% -99.00%
NL
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.